Published February 2025

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed patent ban for NGT plants, plant material and plant products.

By way of reminder, in preparing legislation to relax the regulatory process for the marketing of NGT plants, the EU Parliament proposed an amendment which effectively excluded from patentability “NGT plants, parts thereof, genetic information, and the process features they contain”.  The proposal also included restrictions on the scope of protection of existing patents and applications for all NGT plants.  The purpose of the proposed ban was to avoid legal uncertainties, increased costs and dependencies on large agritech companies for farmers and breeders.  This, they argued, was in line with the EU Commission aim to develop sustainable agriculture and increase food security in the region.

Since the proposed amendment, there has been debate over the scope of the exclusion, which could have been interpreted as extending to the genetic tools used for targeted mutagenesis.  There has also been understandable reluctance in having to revise existing legislation such as the EU Biotech Directive, the UPCA and the Trips agreement, as well as questions over the amendments that might be needed to the European Patent Convention.  Despite softening the proposal to be limited to the lower-risk NGT1 plants only by the Belgian Presidency, they were unable to secure a majority vote.

The current Polish presidency have recognised that in order to implement the regulatory legislation, the deadlock between the EU member states on the proposed patent ban has to be promptly addressed.  With the objective of stimulating innovation in the EU whilst enabling free access to varieties by breeders, the Polish Presidency have proposed the following:

  • There will be a distinction between patents which protect basic technologies and patents for plants and processes which result in a specific plant trait.
  • Reproductive material of an NGT1 plant can be placed on the market without any further restrictions, if it is not protected by a product patent, or a process patent which results in a specific trait of the plant.
  • If there are patents which protect the reproductive material, or which protect a process which results in a specific trait, then the reproductive material can still be put on the market, but it may be subject to further restrictions if a Member State wishes. Such restrictions include: a ban on use of the reproductive material for cultivation of reproductive material and a labelling requirement.  These restrictions would aim to protect national farmers and breeders against patents.
  • The proposal includes a verification procedure to determine the existence of patents or applications which may be relevant, and this burden will fall to the party putting the reproductive material on the market.

It is notable that the provisions don’t relate to plants per se, or plant products but only to reproductive material.  The requirements are also limited to NGT1 plants, and any other reproductive material will not be subject to the verification procedure.

Many have welcomed the removal of the proposed patent ban, and if the Polish proposal is accepted then the legislation may progress forward, although there are still many non-IP related issues to resolve.


This article was prepared by Partners Punita Shah and Ellie Purnell.

Latest updates

Event - 4th November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Event details
Event - 12th October 2026

HGF to attend Festival of Biologics 2026

HGF is pleased to announce that Frédéric Didelon, Partner and European Patent Attorney in our Life Sciences team, will be attending the Festival of Biologics, taking place 13-15 October 2026 …

Event details
Event - 29th October 2026

Join us for HGF’s IP clinic after ETZ EnergyWorks' Brewed for Growth event

Following ETZ EnergyWorks’ Brewed for Growth event on Thursday 29 October, we are hosting our next IP clinic from 10am-1pm, offering practical, confidential advice at no cost. If you’re developing …

Event details
Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
Event - 7th - 10th October 2026

HGF Attending AIPPI World Congress 2026

HGF is attending the AIPPI World Congress 2026, taking place in Hamburg from 7-10 October 2026. Bringing together intellectual property professionals from around the world, the annual Congress is one …

Event details
Event - 12th November 2026

HGF to Host Bionow Biotech & Beers Networking Event in Leeds

HGF is pleased to be partnering with Bionow to host the next Biotech & Beers networking event in Leeds on 12 November 2026, bringing together professionals from across the life …

Event details
Event - 18th November 2026

HGF Venture: Funding the Future

Join fellow life sciences founders, investors and business leaders for an evening of drinks and networking in Cambridge on the 18th November, 5-9pm. Featuring an investor-founder round table and an …

Event details
Event - 22nd September 2026

HGF are sponsors of LSPN Europe 2026

HGF is proud to sponsor LSPN Europe 2026, the premier event for IP professionals in the life sciences sector. Join us on September 22-23 in Basel for two days packed …

Event details